ERGENE, A. O. Et Al. 2022. The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics. Turk Kardiyoloji Dernegi Arsivi , vol.50, no.5 , 356-370.

ERGENE, A. O., Aras, D., Kaymaz, C., ARSAVA, E. M., GÖNEN, C., Gurkaş, E., ... Arslan, U.(2022). The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics. Turk Kardiyoloji Dernegi Arsivi , vol.50, no.5, 356-370.

ERGENE, ASIM Et Al. "The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics," Turk Kardiyoloji Dernegi Arsivi , vol.50, no.5, 356-370, 2022

ERGENE, ASIM O. Et Al. "The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics." Turk Kardiyoloji Dernegi Arsivi , vol.50, no.5, pp.356-370, 2022

ERGENE, A. O. Et Al. (2022) . "The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics." Turk Kardiyoloji Dernegi Arsivi , vol.50, no.5, pp.356-370.

@article{article, author={ASIM OKTAY ERGENE Et Al. }, title={The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics}, journal={Turk Kardiyoloji Dernegi Arsivi}, year=2022, pages={356-370} }